Lithium succinate

Lithium succinate
Clinical data
AHFS/Drugs.com Monograph
ATC code D11AX04 (WHO)
Identifiers
PubChem (CID) 10197702
ChemSpider 8373202 YesY
ECHA InfoCard 100.036.574
Chemical and physical data
Formula C4H5LiO4
Molar mass 124.02 g/mol
3D model (Jmol) Interactive image
  (verify)

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

References

  1. Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel). 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
  2. Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.


This article is issued from Wikipedia - version of the 6/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.